Cannabis
November 27, 2019 | |
Marc Ullman is quoted in a Nutraingredients-USA article, “FDA revises consumer info on CBD, says ingredient is not GRAS, sends 15 CBD warning letters.”
Click here to read the article.
Read MoreNovember 20, 2019 | | |
On December 4-5, Marc Ullman will be speaking at the 4th Annual Dietary Supplement Regulatory Strategy Conference at the Key Bridge Marriott in Arlington, VA.
Topics to be addressed include:
- Ongoing Impact of CBD Use in the Dietary Supplement Industry
- Regulatory Oversight of Social Media Influencers & Supplement Claims
- Interpretation of USDA National Bioengineered
October 29, 2019 | | |
Marc Ullman was quoted in a Nutra ingredients-usa.com article, “Mississippi adds to regulatory tangle with warning on CBD products.”
Click here to read article.
Read MoreOctober 11, 2019 | | |
Marc Ullman will be a speaker at SupplySide West summit, “CBD from Seed to Shelf: The Supply Side Story.” Ullman’s session will be “Legal Eagles: Risk Update, Plus Your Questions Answered.” The Session will take place on Oct. 16 at Mandalay Bay, Las Vegas, NV.
Program Description:
Cannabinoids are on everyone’s mind—consumers, industry, regulators and
Read MoreAugust 16, 2019 | |
Marc Ullman was quoted in a NutraIngredients-usa.com article, “Patchwork quilt of regulations could further complicate CBD picture if FDA doesn’t act quickly.”
Click here to read the article.
Read MoreAugust 13, 2019 | | |
Marc Ullman was quoted in the Long Island Business News’ article, “Confusing Web of Laws Muddles CBD Industry.” The article discusses the confusing web of contradictory laws and inconsistent enforcement in products containing CBD.
The sudden swell in CBD products stems in large part from the passage of the 2018 Farm Bill. CBD is derived
Read MoreApril 19, 2019 | | |
Marc Ullman was quoted in a Natural Products Insider article, “The Vitamin Shoppe to carry CBD following FDA’s move to exercise ‘enforcement discretion.'” The article discusses the FDA’s announcement to exercise “enforcement discretion” related to foods and supplements containing CBD as a factor driving mass-market retailer activity in the category, including The Vitamin Shoppe’s recent move
Read MoreMarch 8, 2019 | |
On April 10, 2019, Marc Ullman and Steven Shapiro will be featured speakers at Supplyside East, presenting on the topic, “What Is the Regulatory Current State of Play with CBD?”
The pair will discuss the latest insights around regulatory issues related to cannabidiol at the international, national and local levels.
Supplyside East, which bills itself
Read MoreMarch 6, 2019 | |
Dr. Scott Gottlieb, who announced his plan to resign as FDA commissioner on March 5, 2019, had in the previous week just announced plans to develop a regulatory framework for CBD.
Marc Ullman spoke with Nutraingredients-USA about what might happen with the CBD initiative for the article entitled “Advocates hopeful that Gottlieb’s departure won’t derail
Read MoreFebruary 28, 2019 | |
Marc Ullman was quoted in a Nutraingredients-USA article, “Gottlieb: FDA plans meeting in April on new CBD regulations.” FDA Commissioner Scott Gottlieb said the agency is planning a public meeting in April to initiate a rule making procedure on CBD.
Click here to read the article.
Read More- AI
- Appeals
- Banking
- Bankruptcy
- Business Dissolution
- Cannabis
- Commercial Litigation
- Complex Torts & Product Liability
- Compliance Investigations & White Collar
- Construction
- Corporate
- Directors & Officers Liability
- Diversity & Inclusion
- Elder Law
- Environment
- General Liability
- Health Services
- Insurance Coverage
- Insurance Fraud
- Intellectual Property
- Labor & Employment
- Medical Malpractice Defense
- Privacy, Data & Cyber Law
- Professional Liability
- Real Estate, Zoning & Land Use
- Tax
- Trusts & Estates